Cannabis use disorder linked to modestly higher breast surgery risks
Postoperative complications following mastopexy and reduction mammaplasty in patients with cannabis use disorder: a propensity-matched cohort study.
AI Summary
This retrospective, propensity-matched cohort study examined whether documented cannabis use disorder (CUD) was associated with complications after mastopexy or reduction mammaplasty. It included 2,444 matched patients, with 1,222 in the CUD group and 1,222 without CUD; patients were matched on demographic factors, comorbidities, and procedure type. Outcomes were assessed over 90 days for surgical-site complications and 30 days for emergency-department visits.
Compared with patients without documented CUD, those with CUD had higher rates of surgical-site infection (3.8% vs 2.0%), seroma or hematoma (3.6% vs 2.0%), and emergency-department visits (14.2% vs 9.6%). Wound dehiscence did not differ significantly (5.6% vs 4.2%). The authors describe the absolute risk differences as small, and this observational study cannot establish that CUD caused the complications or that they were directly attributable to the breast procedure; this is an abstract-based summary, not a full-text review.
π‘ Key Findings
π
Original Abstract
Related Research
Similar Studies
More Addiction research papers you might find interesting.
U.S. survey finds distinct patterns of frequent alcohol, nicotine, andβ¦
Treatment records show a sharp rise in stimulant use in Oman, 2019β2024
An 18-month cohort found adverse outcomes were infrequent, but long-term risksβ¦
Explore More Research
Stay informed about the latest cannabis science.